ImmuCell Corporation (ICCC)

ImmuCell Revenue

In the year 2023, ImmuCell had annual revenue of $17.47M, a decrease of -5.90%. Revenue in the quarter ending December 31, 2023 was $5.10M with 30.30% year-over-year growth.

• Revenue (ttm): $17.47M
• Revenue Growth: -5.90%
• P/S Ratio: 2.28
• Revenue / Employee: $236,104
• Employees: 74
• Market Cap: 39.84M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	17.47M	-1.10M	-5.90%
Dec 31, 2022	18.57M	-675.01K	-3.51%
Dec 31, 2021	19.24M	3.90M	25.43%
Dec 31, 2020	15.34M	1.62M	11.80%
Dec 31, 2019	13.72M	2.74M	24.91%
Dec 31, 2018	10.99M	555.21K	5.32%
Dec 31, 2017	10.43M	887.13K	9.30%
Dec 31, 2016	9.54M	-684.73K	-6.69%
Dec 31, 2015	10.23M	2.63M	34.64%
Dec 31, 2014	7.60M	1.59M	26.46%
Dec 31, 2013	6.01M	617.24K	11.45%
Dec 31, 2012	5.39M	278.79K	5.45%
Dec 31, 2011	5.11M	724.95K	16.53%
Dec 31, 2010	4.39M	-119.56K	-2.65%
Dec 31, 2009	4.51M	-122.55K	-2.65%
Dec 31, 2008	4.63M	-1.44M	-23.74%
Dec 31, 2007	6.07M	1.27M	26.41%
Dec 31, 2006	4.80M	-181.87K	-3.65%
Dec 31, 2005	4.98M	1.29M	34.82%
Dec 31, 2004	3.70M	338.94K	10.10%
Dec 31, 2003	3.36M	-2.83M	-45.72%
Dec 31, 2002	6.18M	-492.06K	-7.37%
Dec 31, 2001	6.68M	1.04M	18.47%
Dec 31, 2000	5.64M	726.74K	14.80%
Dec 31, 1999	4.91M	427.38K	9.54%
Dec 31, 1998	4.48M	-74.81K	-1.64%
Dec 31, 1997	4.56M	116.49K	2.62%
Dec 31, 1996	4.44M	-497.34K	-10.07%
Dec 31, 1995	4.94M	498.78K	11.24%
Dec 31, 1994	4.44M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.